T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Cibus
CBUS
$144M
| $23.7M | ﹤0.01% |
21,561
-3,745
| -15% | -$4.24M |
|
1127
TechnipFMC
FTI
$29.5B
| $23.7M | ﹤0.01% |
1,018,997
-1,134,324
| -53% | -$23.5M |
|
|
UBA
1128
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $23.7M | ﹤0.01% |
1,091,108
-31,210
| -3% | -$698K |
|
|
TSS
1129
DELISTED
Total System Services, Inc.
TSS
| $23.7M | ﹤0.01% |
299,794
-951
| -0.3% | -$69.1K |
|
|
MRO
1130
DELISTED
Marathon Oil Corporation
MRO
| $23.7M | ﹤0.01% |
1,397,047
-87,340
| -6% | -$1.3M |
|
1131
Masco
MAS
$14.7B
| $23.6M | ﹤0.01% |
537,847
-35,200
| -6% | -$1.43M |
|
1132
CMS Energy
CMS
$22B
| $23.6M | ﹤0.01% |
499,231
-9,600
| -2% | -$465K |
|
1133
United Rentals
URI
$70.3B
| $23.6M | ﹤0.01% |
137,149
-7,100
| -5% | -$1.08M |
|
1134
Utah Medical Products
UTMD
$230M
| $23.6M | ﹤0.01% |
289,562
-8,996
| -3% | -$702K |
|
1135
NOV
NOV
$7.45B
| $23.6M | ﹤0.01% |
653,970
-31,233
| -5% | -$1.06M |
|
1136
Celanese
CE
$4.75B
| $23.4M | ﹤0.01% |
218,398
-23,658
| -10% | -$2.51M |
|
1137
Hawkins
HWKN
$2.7B
| $23.4M | ﹤0.01% |
1,327,056
-41,400
| -3% | -$793K |
|
1138
Copart
CPRT
$26.8B
| $23.2M | ﹤0.01% |
2,153,060
-3,320
| -0.2% | -$32.3K |
|
|
RTEC
1139
DELISTED
Rudolph Technologies Inc
RTEC
| $23.2M | ﹤0.01% |
970,513
-31,900
| -3% | -$819K |
|
1140
Quest Diagnostics
DGX
$26.2B
| $23.1M | ﹤0.01% |
234,672
-13,790
| -6% | -$1.31M |
|
1141
CBRE Group
CBRE
$42.7B
| $23.1M | ﹤0.01% |
533,352
-50,600
| -9% | -$2.1M |
|
1142
Eastman Chemical
EMN
$8.29B
| $22.9M | ﹤0.01% |
247,024
-1,388,564
| -85% | -$126M |
|
|
BID
1143
DELISTED
Sotheby's
BID
| $22.9M | ﹤0.01% |
443,376
-2,438
| -0.5% | -$122K |
|
|
IPHI
1144
DELISTED
INPHI CORPORATION
IPHI
| $22.6M | ﹤0.01% |
618,542
-162,801
| -21% | -$6.39M |
|
1145
MakeMyTrip
MMYT
$5.67B
| $22.4M | ﹤0.01% |
751,394
+600
| +0.1% | +$16.6K |
|
1146
Helix Energy Solutions
HLX
$1.49B
| $22.4M | ﹤0.01% |
2,972,568
+2,855,675
| +2,443% | +$20.2M |
|
1147
Mesa Laboratories
MLAB
$631M
| $22.3M | ﹤0.01% |
179,314
-3,066
| -2% | -$429K |
|
1148
Sportsman's Warehouse
SPWH
$46M
| $22.2M | ﹤0.01% |
3,360,261
+432,330
| +15% | +$2.07M |
|
1149
Southern First Bancshares
SFST
$607M
| $22.1M | ﹤0.01% |
536,573
-3,546
| -0.7% | -$141K |
|
1150
Generac Holdings
GNRC
$13.1B
| $22.1M | ﹤0.01% |
445,945
+7,238
| +2% | +$360K |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.